Close Menu

NEW YORK (GenomeWeb) – A team working with Quanterix to adapt its Simoa, or single-molecule array, technology for infectious disease diagnosis has published details about the development of a pair of Simoa assays that can sensitively and specifically detect the toxins responsible for the severe symptoms of Clostridium difficile infection.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

GenomeWeb Premium gives you:
✔ Full site access
✔ Interest-based email alerts
✔ Access to archives

Never miss another important industry story.

Try GenomeWeb Premium now.

You may already have institutional access!

Check if I qualify.

Already a GenomeWeb or 360Dx Premium member?
Login Now.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.

A genetic alteration appears to increase heart failure risk among people of African descent, according to the Washington Post.

Gene editing could be an issue competitive sports need to address soon, four researchers from Arizona State University write at Slate.

In his look back at the past decade, BuzzFeed News' Peter Aldhous writes that direct-to-consumer genetic testing has led to "Facebook for genes."

In Nature this week: genetic "clock" that can predict the lifespans of vertebrates, new assembler called wtdbg2, and more.